Cardinal Health in collaboration with LSPediA hosted the third Investigator workshop with hundreds of manufacturer attendees. In this workshop, Cardinal Health’s Manager of Pharmaceutical Information Technology Jeff Falardeau outlined the current process…
DSCSA implementation will culminate with a deadline of November 27, 2023. The statutory components will enforce Interoperable Exchange and Verification at the package level by the unique product identifier. As the pharmaceutical…
With 2021 coming to a close in two weeks and the holidays right around the corner, LSPediA held its year-end Customer Advisory Board Meeting virtually on Tuesday, Dec. 14. CEO Riya Cao directed the…
Following the first workshop on Nov. 17, 2021, Cardinal Health is getting well into onboarding its’ suppliers in preparation for their strategic November 2022 deadline. With that comes working through…
Save the date! The HDA Distribution Management Conference and Expo (DMC) is returning in 2022 as an in-person event after two years of virtual participations. LSPediA will present as a platinum-level sponsor in…
The coronavirus outbreak has affected virtually every aspect of our daily lives at some point in the last 18 months. In the midst of so much political and sociological turmoil,…
The clock is ticking. A worthy goal hangs in the balance as an impending timeline looms, testing the readiness of pharmaceutical companies across the country. This is about the aim of…
Save the Date! LSPediA will hold the next Customer Advisory Board (CAB) Meeting on Tuesday, Dec. 14 at 11AM EST. We are excited to announce that our CEO Riya Cao…
As one of the Big 3 wholesale drug distributors in the US and the biggest employer in Ohio, Cardinal Health onboarding 450 manufacturer trading partners for EPCIS data exchange in…
The FDA panel heard from a variety of stakeholders and representatives of the pharmaceutical industry, who shared updates and concerns regarding the implementation of data serialization standards which will take effect in November 2023.
The heart of the challenge to 2023’s requirement is the EPCIS data exchange and the inevitable data errors associated with data exchange. Trading partners who fall behind the compliance mandate may face significant compliance and business risks ahead.
